As of December 2024, Actinium Pharmaceuticals has a market cap of $51.81M. This makes Actinium Pharmaceuticals the world's 25031th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $157.08M | 12.80% |
2023 | $139.26M | -52.30% |
2022 | $291.95M | 77.20% |
2021 | $164.75M | -22.95% |
2020 | $213.82M | 19.27% |
2019 | $179.28M | -43.67% |
2018 | $318.27M | -41.72% |
2017 | $546.07M | -24.11% |
2016 | $719.60M | -72.91% |
2015 | $2.66B | -45.16% |
2014 | $4.84B | 0.00% |
2013 | $4.84B | 292.67% |
2012 | $1.23B | - |